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The complete amino acid sequence of proapolipoprotein (proapo) A-I of chicken high density lipoproteins 
was determined by sequencing overlapping peptides produced by trypsin, S. aureus V8 protease, and cyano- 
gen bromide cleavage. There are 240 amino acid residues in mature chicken apoA-I. By direct sequence 
analysis of a cyanogen bromide peptide, we also determined the sequence of a 6-amino-acid prosegment 
which is present at approx. 10% the molar amount of the mature peptide in chicken plasma. Sequence com- 
parison among apoA-I from chicken, human, rabbit, dog and rat, and secondary structure analysis indicate 
that while the degree of sequence homology is only moderate (< 50% between chicken and man), there is 
good conservation of apoA-I secondary structure, especially in the N-terminal two-thirds of the protein in 
these widely separated species. 
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1. INTRODUCTION 
Apolipoprotein (apo) A-I is the major apopro- 
tein in high density lipoproteins (HDL). There is 
an inverse relationship between the propensity to 
develop atherosclerosis and the plasma HDL and 
apoA-I  concentrations [1-3]. ApoA-I  is implicated 
in the transport of cholesterol from the peripheral 
tissues to the liver for disposal [4,5]. The protein 
was found to be a necessary co-factor for the ac- 
tivation of the enzyme lecithin-cholesterol 
acyltransferase [6,7]. Mammalian apoA-I is 
secreted from the liver as a mixture of proapoA-I  
and mature apoA-I [8-10]. ProapoA-I  can be pro- 
cessed to the mature protein by an enzyme present 
in plasma HDL, mesenteric lymph, and lymph 
chylomicrons [11]. 
In the chicken, previous studies suggest that 
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HDL apoA-I is present exclusively as the mature 
protein [12]. The proapoA-I  was thought o be ef- 
ficiently processed to its mature form in the Golgi 
apparatus and the prosegment was reported to 
have an identical sequence to the human apoA-I 
propeptide [12]. Furthermore, chicken apoA-I is 
synthesized in numerous peripheral tissues and 
serves as a model for cellular cholesterol efflux 
[13]. For these reasons, the primary structure of 
chicken apoA-I and its propeptide is of interest in 
our understanding of apoA-I function and 
metabolism. 
2. MATERIALS AND METHODS 
2.1. Chicken apoA-I purification, enzymatic 
cleavage and peptide &olation 
Laying White Leghorn hen plasma was obtained 
from Texas Animal Specialties. ApoA-I  was 
purified from the plasma high density lipoproteins 
as described [141. The protein (5 mg/ml,  0.1 M 
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NH4HCO3, pH 8.0) was completely digested with 
trypsin or S. aureus V8 protease (en- 
zyme/substrate, 1:50) at room temperature. En- 
zymatically or chemically cleaved peptides were 
purified on either a Waters or a Beckman HPLC 
system. The peptides were initially separated on a 
Vydac Cls reversed-phase HPLC column (250 × 
4.6 mm) at 50°C at a flow rate of 1.5 ml/min. The 
tryptic and S. aureus V8 protease digests were 
separated using 0.1% trifluoroacetic a id (TFA) in 
water as the starting buffer A, and 0.08% TFA in 
95% acetonitrile and 5% water as buffer B. A 
linear gradient of buffer B was increased from 0 to 
60% at a rate of l%/min. Peptides were detected 
by their absorbance at 220 nm. The eluent under 
each peak was collected manually in a tube and 
dried by a Speedvac (Savant Instruments, NY). 
The purity of each peak fraction was checked by 
the manual sequencing method. The pure peptides 
were then sequenced; the partially purified frac- 
tions were subjected to rechromatography with a 
Hypersil C18 column (250 x 4.6 mm) using a 
phosphate buffer system. Buffer A was 0.005 M 
sodium phosphate, pH 6.0; buffer B was 10% buf- 
fer A plus 90% acetonitrile [15]. 
2.2. Amino acid and sequence analyses 
Chicken apoA-I or pure peptides were first 
hydrolyzed in the gas phase with 6 M HCI in a 
Waters hydrolysis apparatus for 1 h at 150°C. 
After hydrolysis, the samples were dried and 
prepared for amino acid analysis using precolumn 
derivatization with phenyl isothiocyanate [16]. 
Sequence determination of shorter peptides 
(< 20 residues) was performed according to Chang 
et al. [171 using a modified Edman reagent, 
dimethylaminoazobenzene isothiocyanate, and 
TLC [17,18] or HPLC [19] methods. The se- 
quences of the protein and larger peptides were 
determined by a gas-phase sequenator with an on- 
line PTH amino acid analyzer from Applied 
Biosystems. 
2.3. C-terminal analysis with carboxypeptidase Y 
The protein (2 nmol) was dissolved in 0.1 N 
pyridine acetate, pH 6.0, and then digested with 
100/zl of Pierce immobilized carboxypeptidase Y 
(10-14 U/ml) at room temperature for 1, 2, 4 and 
24 h. To check for autodigestion by carboxypep- 
tidase Y, the same amount of enzyme was in- 
cubated and sampled simultaneously. Samples 
were dried and coupled with PITC for PTC amino 
acid analysis using a Waters Pico-Tag amino acid 
analyzer. 
2.4. Secondary structure predictions 
Algorithms for secondary structure predictions 
were those described by Eisenberg et al. [201 for 
helical hydrophobic moment, and Kyte and 
Doolittle [21] for relative hydrophobicity. 
3. RESULTS 
The amino acid composition of chicken apoA-I 
reveals that there is no cysteine in chicken apoA-I. 
Therefore, the structural analysis of the protein us- 
ing enzymatic or chemical cleavage was performed 
directly. 
3.1. Tryptic peptides (fig.l) 
The tryptic peptide mixtures of chicken apoA-I 
were purified by a Waters HPLC system on a 
Vydac C~8 column with the TFA buffer system. 
The fractions which required rechromatography 
with the sodium phosphate buffer system for 
purification were T27, T36, T1, T20, T29 and T30. 
36 of the tryptic peptides were purified and 
characterized. These peptides covered most of the 
chicken apoA-I sequence xcept for four dipep- 
tides, namely TK (position 100,101), QR (position 
122,123), ER (position 221,222) and NR (position 
232,233) which might have eluted within the void 
volume. Rechromatography of fractions coming 
out of 16% B with the sodium phosphate buffer 
system showed that T1, T20, T29 and T30 had 
been purified. 
3.2. S. aureus V8 protease peptides and cyanogen 
bromide peptides (fig. 1) 
Most of the S. aureus V8 peptides were purified 
to homogeneity by chromatography on HPLC 
with the TFA buffer system on a Vydac C18 col- 
umn. 28 peptides were sequenced. They provided 
sequence information which allowed the alignment 
of the tryptic peptides. 5 mg of the protein were 
used for this cleavage with 50-times (by wt) of 
cyanogen bromide. Peptides CN1 ,CN4 provid- 
ed additional sequence and overlaps for chicken 
apoA-I. 
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Fig.1. Complete amino acid sequence of chicken apoA- 
I. T, tryptic peptides; S, peptides from digestion with S. 
aureus V8 protease; CN, cyanogen bromide peptides; 
, gas-phase sequencing; ~,  modified Edman manual 
sequencing; CPY, carboxypeptidase Y analysis. 
3.3. Alignment of peptides and complete amino 
acid sequence of chicken proapoA-I 
The amino acid sequence of chicken apoA-I was 
determined primarily by aligning overlapping pep- 
tides of the three digestions. Based on the results of 
cyanogen bromide cleavage, chicken plasma apoA- 
I consists of 90% mature apoA-I and 10% 
proapoA-I. The sequence of the propeptide is Arg- 
Ser-Phe-Trp-Gln-His. The N-terminus of mature 
chicken apoA-I was confirmed as Asp by direct se- 
quencing of the first 30 residues of the intact pro- 
tein. The C-terminus of chicken apoA-I was 
identified as Ala by carboxypeptidase Y cleavage 
of the whole protein. Chicken apoA-I has 240 
amino acid residues with the sequence shown in 
fig. 1. This sequence is similar to the primary struc- 
ture deduced from a recently published cDNA se- 
quence, except for Glu-124 which was predicted to 
be Lys in the DNA-deduced sequence [22]. We 
have also sequenced a complete chicken apoA-I 
cDNA clone which reads GAG for codon 124 
predicting a Glu in this position (Byrnes, L. and 
Chan, L., unpublished). 
4. DISCUSSION 
4.1. Amino acid sequence of chicken proapoA-I 
We have determined the complete amino acid se- 
quence of chicken proapoA-I by the direct sequen- 
cing of overlapping peptide fragments. The 
6-amino-acid propeptide sequence determined in 
this study, Arg-Ser-Phe-Trp-Gln-His, differs by 
two residues from that of Banerjee t al. [12], Arg- 
His-Phe-Trp-Gln-Gln, which was determined by 
radiolabeling and immunochemical techniques 
[12]. Interestingly', the latter sequence is identical 
to that in man [23]. Our propeptide sequence has 
also been confirmed by that predicted from cloned 
apoA-I cDNA (Byrnes, L. and Chan, L., un- 
published). The N-terminal 20 amino acid residues 
of the mature chicken apoA-I have been reported 
previously by two laboratories [12,24]. Our se- 
quence matches that presented by Shackelford and 
Lebherz [24], but differs from that by Banerjee t 
al. [12] in that Tyr-17 was reported as Thr-17 in the 
latter sequence. Whether the apparent discrepan- 
cies between our data and those of Banerjee t al. 
[12] in the prosegment and in the N-terminal 
region represent rue sequence heterogeneity is 
unclear at present. 
4.2. ProapoA-I in chicken plasma 
A previous study on chicken apoA-I synthesis 
suggests that in the liver, intracellular im- 
munoreactive apoA-I is a mixture of proapoA-I 
and mature apoA-I, whereas the plasma protein is 
exclusively in the form of the mature protein [12]. 
Our current analysis by direct peptide sequencing 
indicates that proapoA-I constitutes approx. 10% 
of the plasma protein. The different observations 
between the two studies could be explained by: (i) 
the more sensitive nature of the direct sequencing 
of CN peptides and/or (ii) the proapoA-I being 
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derived mainly from the intestine; and/or (iii) the 
different source of animals used, though leghorns 
were used in both laboratories. We conclude that 
at least in our animals, the cellular processing of 
proapoA-I is not 100070 efficient. There is, 
however, no information on the relative stabilities 
of chicken plasma mature apoA-I vs proapoA-I 
which would influence the steady-state concentra- 
tions of these protein species. 
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Fig.2. Comparison of the amino acid sequence of 
chicken apoA-I with apoA-I sequences from other 
vertebrates. CH, chicken; HU, human [30]; RB, rabbit 
[31]; DG, dog [32]; RA, rat [33]. 
In both human and rat proapoA-I, the 6-amino- 
acid prosegment ends with a C-terminal Gin-Gin 
dipeptide [8-10,25], unusual amino acids for pro- 
tein precursors that are processed proteolytically. 
In the chicken, the Gln-Gln pair is replaced by Gin- 
His, indicating that the requirement for Gin in the 
cleavage site is not absolute. Furthermore, the pro- 
segment is efficiently processed in the chicken liver 
([12] and present study), whereas in the rat and 
human, it is almost otally uncleaved as the nascent 
polypeptide chain is secreted from the liver 
[8,26,27]. Whether the difference in structures of 
the substrate (proapoA-I) accounts for some of the 
difference in processing efficiency is unclear. Com- 
parative studies using the mammalian vs chicken 
enzyme(s) and mammalian vs chicken proapoA-I 
as substrates will shed some light on the 
mechanism of proapoA-I processing in the liver 
and intestine. 
The presence of a prosegment and of the specific 
processing enzyme(s) in the chicken indicates that 
the processing pathway evolved before the 
divergence of the avian species, some 270 million 
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Fig.3. Secondary structure analysis of chicken and 
human apoA-I. The helical hydrophobic moment was 
determined by the algorithm of Eisenberg et al. [20], and 
the hydrophobicity according to Kyte and Doolittle [21]. 
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is unknown, the conservation of the pathway sug- 
gests that it may be important o the overall func- 
tion of apoA-I in HDL metabolism. 
4.3. Sequence alignment and structure of chicken 
apoA-I 
The amino acid sequence of chicken apoA-I can 
be readily aligned to those of the human, rabbit, 
dog and rat proteins (fig.2). As expected, the 
degree of homology between avian and mam- 
malian apoA-I is less than that among the mam- 
malian proteins themselves. ApoA-I  is an 
interesting molecule because the human protein 
contains tandem repeats of 11 and 22 amino acid 
residues [28,29]. Despite the considerable 
divergence of the avian sequence, similar repeats 
of 11- and 22-mers can also be identified in the 
chicken (not shown, see also [22]). When predic- 
tive algorithms are used to analyze human and 
chicken apoA-I, it is evident that the secondary 
structures are generally well conserved between 
these species as indicated by the similar patterns in 
the helical hydrophobic moment [20] and 
hydrophobicity profiles [21] (fig.3). The conserva- 
tion appears to be better in the N-terminal two- 
thirds of the protein. The avian and mammalian 
lineages have diverged for -270 million years, and 
the sequence homology between the human and 
avian proteins is less than 50%. In the face of this 
degree of divergence in primary sequence, it is 
remarkable that there is such a well-conserved 
secondary structure. 
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